Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain-Reference-Cited by-同舟云学术

Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain

Published:2014-01 Issue: Volume:84 Page:342-353
ISSN:1053-8119
Container-title:NeuroImage
language:en
Short-container-title:NeuroImage

Author:

Finnema Sjoerd J.,Stepanov Vladimir,Ettrup Anders,Nakao Ryuji,Amini Nahid,Svedberg Marie,Lehmann Charlotte,Hansen Martin,Knudsen Gitte M.,Halldin Christer

Funder

Lundbeck Foundation

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Neurology

Reference65 articles.

1. Patients with obsessive–compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei;Adams;Int. J. Neuropsychopharmacol.,2005

2. A new look at the statistical model identification;Akaike;IEEE Trans. Autom. Control,1974

3. In-target produced [11C]methane: increased specific radioactivity;Andersson;Appl. Radiat. Isot.,2009

4. Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: positron emission tomography examination and metabolite analysis in cynomolgus monkeys;Andersson;Synapse,2010

5. Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography;Biver;Eur. J. Nucl. Med.,1994

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging the 5-HT_2C receptor with PET: Evaluation of 5-HT_2C and 5-HT_2A affinity of pimavanserin in the primate brain;Journal of Cerebral Blood Flow & Metabolism;2024-08-21

2. Exploring mechanisms of psychedelic action using neuroimaging;Nature Mental Health;2024-02-09

3. Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms;Neuroscience Applied;2023-12

4. Neuroimaging in psychedelic drug development: past, present, and future;Molecular Psychiatry;2023-09

5. Psychedelic therapy in the treatment of addiction: the past, present and future;Frontiers in Psychiatry;2023-06-12